Quang A. Le, PharmD, PhD
College of Pharmacy
- B.S. University of California, Los Angeles
- Pharm.D. Loma Linda University
- Ph.D. University of Southern California
Health Economics, Modeling and Simulation, Health-Related Quality of Life Methodology, Large Database Analysis.
Dr. Le currently serves on the Editorial Advisory Board for the Journal Medical Decision Making (5-year Impact Factor = 3.649) and Medicine (5-year Impact Factor = 2.082). His original research has been published in major journals such as Journal of Managed Care & Specialty Pharmacy, Medical Care; Medical Decision Making; Quality of Life Research, and Value in Health; among other major medical journals (Cancer, Breast Cancer Research & Treatment, Journal of Clinical Psychiatry, and Surgery for Obesity and Related Diseases, etc.). He is also active member of the American Society of Clinical Oncology (ASCO), International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Society for Medical Decision Making (SMDM), International Society for Quality of Life Research (ISOQOL), and American Association of Colleges of Pharmacy (AACP).
Research Grants and Contracts
- PhRMA Foundation - Value Assessment Research Award (Grant)
- PhRMA Foundation - Value Assessment Challenge Award (Third-Place Winner)
- Radius Health, Inc. (Research Contract)
- AACP New Investigator Award (Grant)
- Genentech Inc. – BioOncology (Research Consultant)
- National Institutes of Health, National Institute of Mental Health (Grant – Research Consultant)
- National Institutes of Health, National Library of Medicine (Co-Investigator)
Le QA. Patient-Level Modeling Approach using Discrete-Event Simulation: A Cost-Effectiveness Study of Current Treatment Guidelines for Women with Postmenopausal Osteoporosis. J Manag Care Spec Pharm 2019; 25 (10):1089-1095 (PubMed ID: 31556816).
Le QA, Hay JW, Russell B, Wang Y. Cost-Effectiveness Analysis of Sequential Treatment of Abaloparatide followed by Alendronate versus Teriparatide followed by Alendronate in Postmenopausal Women with Osteoporosis in the United States. Annals of Pharmacotherapy 2019;53(2):134-143 (PubMed ID: 30160186).
An JJ, Le QA. Dang T. Association between different types of comorbidity and disease burden in patients with diabetes. Journal of Diabetes 2019;11(1):65-74 (PubMed ID: 29956479).
Tai B-W, Bae Y, Le QA. A Systematic Review of Health Economic Evaluation Studies using the Patient's Perspective. Value in Health 2016;19(6):903-908 (PubMed ID: 27712720).
Lee JH, Nguyen QN, Le QA. “Comparative Effectiveness of Three Bariatric Surgery Procedures: Roux-en-Y Gastric Bypass, Laparoscopic Adjustable Gastric Band, and Sleeve Gastrectomy.” Surgery for Obesity and Related Diseases 2016;159(3):565-73 (PubMed ID: 27572338).
Le QA. “Structural Uncertainty of Markov Models for Advanced Breast Cancer: A Stimulation Study of Lapatinib.” Medical Decision Making 2016; 36(5): 629-40 (PubMed ID: 26753626).
Le QA, Doctor JN, Feeny NC, Zoellner LA. Cost-Effectiveness of Prolonged Exposure Therapy versus Pharmacotherapy and Treatment Choices in Posttraumatic Stress Disorder (The OPT Trial): A Doubly Randomized Preference Trial. Journal of Clinical Psychiatry 2014; 75(3):222–230 (PubMed ID: 24717377).
Le QA, Probabilistic Mapping of the Health-Status Measure SF-12 onto the Health-Utility Measure EQ-5D using the U.S. Population-based Scoring Models. Quality of Life Research; 2013; 23(2):459-66 (PubMed ID: 24026631).
Le QA, Doctor JN, Zoellner LA, Feeny NC. Miniumal Clinically Important Differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): Results from a Doubly Randomized Preference Trial (DRPT). Health and Quality of Life Outcomes 2013; 11:59 (PubMed ID: 23587015).
Le QA, Strylewicz G, Doctor JN. Detecting Blood Laboratory Errors Using a Bayesian Network: An Evaluation on Liver Enzyme Tests. Medical Decision Making 2011; 31(2):325-337 (PubMed ID: 20729509).
Le QA, Hay JW. Cost-Effectiveness Analysis of Lapatinib in HER2-Positive Advanced Breast Cancer. Cancer 2009; 115(3):489-498(Pubmed ID: 19117341).